Influence factors and predictors in anti-viral therapy for chronic hepatitis C.

被引：0
|
作者：
金生
周卫平
张大志
机构：
[1] 重庆医科大学病毒性肝炎研究所
[2] 重庆医科大学病毒性肝炎研究所 400010
来源：
中华肝脏病杂志 | 2004年 / 02期
关键词：
肝炎; 丙型; 慢性; 抗病毒治疗; 影响因素; 预测因素;
D O I：
暂无
中图分类号：
R512.63 [];
学科分类号：
100401 ;
摘要：
慢性丙型肝炎的抗病毒治疗仍然是个难题。了解丙型肝炎抗病毒治疗的影响因素,早期准确地对干扰素治疗应答进行预测,可减少或消除不必要的或无效的治疗,对不同情况、不同个体采用更灵活的治疗方案,可提高治疗的效价比。 1.丙型肝炎病毒基因型:基因型的检测对抗丙型肝炎病毒(HCV)治疗的选择极为重要,在HCV感染中,基因1型最为常
引用
收藏
页码：69 / 70
页数：2
相关论文
共 10 条
  • [1] Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response[J] . Philippe Halfon,Hacene Khiri,Albert Tran,Guillaume Pénaranda,Jerome Courcambeck,Hélene Joly,Denis Ouzan. European Journal of Gastroenterology & Hepatology . 2003 (10)
  • [2] High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C
    Bressler, BL
    Guindi, M
    Tomlinson, G
    Heathcote, J
    [J]. HEPATOLOGY, 2003, 38 (03) : 639 - 644
  • [3] Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
    Davis, GL
    Wong, JB
    McHutchison, JG
    Manns, MP
    Harvey, J
    Albrecht, J
    [J]. HEPATOLOGY, 2003, 38 (03) : 645 - 652
  • [4] Dynamics of alanine aminotransferase during hepatitis C virus treatment
    Ribeiro, RM
    Layden-Almer, J
    Powers, KA
    Layden, TJ
    Perelson, AS
    [J]. HEPATOLOGY, 2003, 38 (02) : 509 - 517
  • [5] Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-α and ribavirin treatment for chronic hepatitis C virus infection
    Sreenarasimhaiah, J
    Jaramillo, A
    Crippin, J
    Lisker-Melman, M
    Chapman, WC
    Mohanakumar, T
    [J]. HUMAN IMMUNOLOGY, 2003, 64 (05) : 497 - 504
  • [6] Nonimmune complexed HCV RNA titer in serum as a predictor of interferon response in patients with chronic hepatitis C
    Fujita, N
    Kaito, M
    Takeo, M
    Iwasa, M
    Ikoma, J
    Watanabe, S
    Adachi, Y
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (03): : 645 - 652
  • [7] Pretreatment laparoscopic appearance of the liver can predict response to combination therapy with interferon alpha 2B and ribavirin in chronic hepatitis C
    Bajaj, JS
    Molina, E
    Regev, A
    Schiff, ER
    Jeffers, LJ
    [J]. GASTROINTESTINAL ENDOSCOPY, 2003, 58 (03) : 380 - 383
  • [8] Chronic hepatitis C patients with a post‐treatment virological relapse re‐treated with an induction dose of 18?MU interferon‐α in combination with ribavirin and amantadine: a two‐arm randomized pilot study[J] . C. J.Weegink,R. E.Sentjens,M. G.Beld,M. G. W.Dijkgraaf,H. W.Reesink. Journal of Viral Hepatitis . 2003 (3)
  • [9] Early viral kinetics on treatment with pegylated interferon‐α‐2a in chronic hepatitis C virus genotype 1 infection*[J] . W.Jessner,R.Stauber,F.Hackl,C.Datz,T.Watkins‐Riedel,H.Hofer,A.Gangl,H.Kessler,P.Ferenci. Journal of Viral Hepatitis . 2003 (1)
  • [10] Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C
    Fernández, I
    Castellano, G
    de Salamanca, RE
    Colina, F
    de la Cámara, A
    Morán, MJ
    Muñoz, R
    Solís-Herruzo, JA
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (03) : 314 - 319
1